Patent details
EP2197438 Title: HETEROCYCLIC COMPOUNDS AS CRTH2 RECEPTOR ANTAGONISTS
Basic Information
- Publication number:
- EP2197438
- PCT Application Number:
- PCT/US/2008/079303
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP088382114
- PCT Publication Number:
- WO/2009/049021
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- HETEROCYCLIC COMPOUNDS AS CRTH2 RECEPTOR ANTAGONISTS
- French Title of Invention:
- COMPOSÉS HÉTÉROCYCLIQUES COMME ANTAGONISTES DU RÉCEPTEUR CRTH2
- German Title of Invention:
- HETEROCYCLISCHE VERBINDUNGEN ALS CRTH2-REZEPTOR-ANTAGONISTEN
- SPC Number:
Dates
- Filing date:
- 09/10/2008
- Grant date:
- 15/07/2015
- EP Publication Date:
- 15/07/2015
- PCT Publication Date:
- 16/04/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 23/06/2010
- EP B1 Publication Date:
- 15/07/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 09/10/2015
- Expiration date:
- 09/10/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 09/10/2008
- Name:
- CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY
- Address:
- No. 226, Huanghe Street, Shijiazhuang Hebei 050035, China (CN)
- Name:
- Centaurus BioPharma Co. Ltd.
- Address:
- Building No. 16 Tsinghua Science Park Yuquan Wisdom Vale, Beijing 100195, China (CN)
Inventor
- Name:
- YUAN Wei, W.
- Address:
- United States (US)
Priority
- Priority Number:
- 998298 P
- Priority Date:
- 10/10/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07D 471/14;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|